Business Development

BARD1 is seeking commercialisation partners for our current diagnostic programs, pending the results of our planned Clinical Validation studies.

We also welcome interest from potential partners to discuss research collaboration or strategic alliance opportunities to expand the diagnostic and therapeutic potential of the BARD1 technology.

Please contact our Chief Executive Officer, Dr Leearne Hinch on +61 400414416 or